Accu-Break Pharmaceuticals, Inc. Company Profile
Accu-Break Pharmaceuticals, Inc. (ABP) is a technology licensing and product development company. ABP has invented, developed and patented a suite of novel Accu-Break⢠technologies that enable pharmaceutical tablets to be made that can be subdivided by hand into accurate partial doses with the intent of making it easier and safer for patients to adjust their dose. The Company is currently developing its first Accu-Break product, an Accu-Break-formatted anticoagulant, and is licensing the Accu-Break technologies for use in other products that are currently in development. ABP currently has 17 patents issued and 37 patents pending worldwide.
News Articles
Accu-Break, Alembic in new Accu-Break tablets development agreement
Alembic Pharmaceuticals has entered into a license agreement with Accu-Break Pharmaceuticals (ABP) to develop new brand products that will use ABP's Accu-Break tablet technologies.
Alembic-Accu-Break alliance targets dosage convenience
India's Alembic Pharmaceuticals and Accu-Break Pharmaceuticals have entered into a development and licence pact to develop new branded products based on the US firm's Accu-Break tablet technologies....
Accu-Break, Alembic enter into product development and license agreement
India-based Accu-Break Pharmaceuticals (ABP) has entered into a development and license agreement with Alembic Pharmaceuticals of Plantation, Fla., to develop new brand products that will use ABP’s...
Accu-Break and Alembic join in tablet-splitting tech accord
Tablet technology firm Accu-Break Pharmaceuticals has signed a product development and licensing agreement with Indian generic drugmaker Alembic Pharmaceuticals.
ABP, Alembic enter into development and license agreement for Accu-Break tablet technologies
Accu-Break Pharmaceuticals, Inc. announced today that it has entered into a development and license agreement with Alembic Pharmaceuticals Limited of Gujarat, India to develop new brand products that...
Roche launches new Accu-Chek Nano SmartView system
Roche Diabetes Care, a manufacturer of Accu-Chek products, has launched new Accu-Chek Nano SmartView system.
Roche Diabetes Care announces availability of new ACCU-CHEK Nano SmartView System
Roche Diabetes Care, makers of ACCU-CHEK products and services, is pleased to announce the availability of the new, user-friendly ACCU-CHEK Nano SmartView System.
The system will be available in the United States in the second half of 2012. Roche announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) for the Accu-Chek Co...
Drugs and Medications
Kerol ad [PharmaDerm, A division of Nycomed US Inc.]
Kerol™ AD(45% urea emulsion) Accu-Dose In a zinc undecylenate and lactic acid vehicle
Neutrogena clear face break-out free sunscreen [Neutrogena Corporation]
Neutrogena Clear Face Break-Out Free Liquid Lotion Sunscreen SPF 55
Neutrogena clear face break-out free sunscreen [Neutrogena Corporation]
Neutrogena Clear Face Break-Out Free Liquid Lotion Sunscreen SPF 30
Exuviance intense lightening complex [NeoStrata Company Inc]
Exuviance Intense Lightening Complex
Chapstick moisturizer [Pfizer Consumer Healthcare]
ChapStick MoisturizerChapStick Moisturizer Vanilla MintChapStick Moisturizer Green Apple(octinoxate, oxybenzone, and white petrolatum)
PubMed Articles
Abstract Background: Hemolyzed specimens are the leading pre-analytical problem in the laboratory practice, and exert a negative impact on test results. We assessed the reliability of Beckman Coulter...
Genetic analysis of contiguous X-chromosome deletion syndrome encompassing the BTK and TIMM8A genes.
Patients with X-linked agammaglobulinemia (XLA) can present with sensorineural deafness. This can result from a gross deletion that not only involved the Bruton's tyrosine kinase (BTK) gene, but also...
Abstract Objectives. The aim of this study was to compare the early diagnostic value of the Roche high-sensitive troponin T (Hs-TnT) and that of conventional troponins. Design. A total of 233 consecut...
53BP1-mediated DNA double strand break repair: Insert bad pun here.
53BP1 is an established player in the cellular response to DNA damage and is a canonical component of ionizing-radiation induced foci - that cadre of proteins which assemble at DNA double strand break...
Clinical Trials
Remote Management of Diabetic Patients Via Data Transmission by Accu-Chek 360 Software
The purpose of this study is to determine if providing some care to diabetic patients remotely, using Accuchek 360 yields at least the same clinical results for their diabetes care, accord...
Injury Incidence in Professional Soccer
The winter break within the German Professional Football Leagues will be shortened as for the season 2009/2010 from 6.5 to 3.5 weeks. That might have repercussions on injury incidence in e...
Tear Film Break-up Time After Instillation of Artificial Tears
This study is an exploratory trial evaluating the tear film break-up time after a single eye drop instillation of over-the-counter artificial tears. The primary hypothesis is that tear fil...
This is a pilot trial to establish study procedures that allow comparison of various starting basal rate profiles used in Continuous Subcutaneous Insulin Infusion (CSII). Glycemic control...
Tear Film Break-Up Time Evaluation of FID 114657
To evaluate the effects of FID 114657 on tear film break-up time in dry eye patients.
Companies
Accu-Break Pharmaceuticals, Inc.
Accu-Break Pharmaceuticals, Inc. (ABP) is a technology licensing and product development company. ABP has invented, developed and patented a suite of novel Accu-Breakâ¢...
Break Media is a leading creator, publisher, and distributor of digital entertainment content including video, editorial, and games. The company's properties include the largest h...
Roche Diabetes Care is a pioneer in the development of blood glucose monitoring systems and a global leader for diabetes management systems and services. For more than 30 years, Roche has been committ...
We dedicate all our resources to analyze small and medium sized companies in the areas of: Medical devices Pharmaceuticals Biotechnology Our mission is to identify quality growth stocks, strategical...
More Information about "Accu-Break Pharmaceuticals, Inc." on BioPortfolio
We have published hundreds of Accu-Break Pharmaceuticals, Inc. news stories on BioPortfolio along with dozens of Accu-Break Pharmaceuticals, Inc. Clinical Trials and PubMed Articles about Accu-Break Pharmaceuticals, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Accu-Break Pharmaceuticals, Inc. Companies in our database. You can also find out about relevant Accu-Break Pharmaceuticals, Inc. Drugs and Medications on this site too.
